Find More Contacts for Hopelab
Protected Content
Non-Management, Executive Engineering, Finance
2 emails found 1 phone number found
View contacts for Hopelab to access new leads and connect with decision-makers.
View All Contacts
  • Company Type Non-profit
  • Investor Type  Venture Capital
  • Investment Stage  Early Stage Venture, Grant, Seed, Venture
  • Number of Exits 
  • Contact Email hi@hopelab.org
  • Phone Number 415-818-8400

Hopelab is a social innovation lab and impact investor advancing entrepreneurs, research, digital health, and solutions that support and empower young people, especially those from historically underserved communities. The organization works to remove systemic barriers to youth mental health and emotional well-being through targeted social impact

investments, hands-on design and research support for digital innovation, and translational science partnerships. Learn more at hopelab.org.

Lists Featuring This Company

Female Founded Early Stage Venture Investors with Investments in Southern US
620 Number of Organizations â€¢ $3.8B Total Funding Amount â€¢ 285 Number of Investors
United States Grant Investors
320 Number of Organizations â€¢ $4.5B Total Funding Amount â€¢ 31 Number of Investors
Health Care Seed Stage Companies With Less Than $50M in Revenue
5,228 Number of Organizations â€¢ $10.4B Total Funding Amount â€¢ 13,956 Number of Investors
Venture Capital Investors with Investments in Greater San Diego Area
1,693 Number of Organizations â€¢ $89.8B Total Funding Amount â€¢ 478 Number of Investors

Frequently Asked Questions

Where is Hopelab's headquarters? Hopelab is located in San Francisco, California, United States.Who invested in Hopelab? Hopelab is funded by Omidyar Network.How much funding has Hopelab raised to date? Hopelab has raised .When was the last funding round for Hopelab? Hopelab closed its last funding round on Feb 20, 2006 from a Angel round.Who are Hopelab's competitors? Alternatives and possible competitors to Hopelab may include CAMHRecoveryLink, and Kaiser Permanente.